Hepatocellular carcinoma: diagnosis, molecular pathogenesis, biomarkers, and conventional therapy

Assessment of superiority of HSP70-targeting aptamer-functionalized drug-nanocarrier over non-targeted commercially available counterpart in HCC therapy: in vitro …

S Chakraborty, A Chakraborty, B Mukherjee, SE Besra… - Life Sciences, 2023 - Elsevier
Aims This research aims to compare the therapeutic potential of target-specific
phosphorothioate backbone-modified aptamer L5 (TLS9a)-functionalized paclitaxel (PTX) …
被引用次数：2 相关文章 所有 3 个版本

H-ras-targeted genetic therapy remarkably surpassed docetaxel treatment in inhibiting chemically induced hepatic tumors in rats

A Mukherjee, R Sen, A Al Hoque, TK Giri, B Mukherjee - Life Sciences, 2024 - Elsevier
Aims Hepatocellular carcinoma (HCC) is still a leading cause of cancer-related death
worldwide. But its chemotherapeutic options are far from expectation. We here compared H …
相关文章 所有 3 个版本